GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Interest Expense

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Interest Expense : HK$-0.7 Mil (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's interest expense for the three months ended in Sep. 2024 was HK$ -2.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was HK$-0.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Operating Income for the three months ended in Sep. 2024 was HK$ -28.1 Mil. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2024 was HK$ -2.6 Mil. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Interest Expense Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.64 -1.29 -1.72 -3.35 -0.63

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -0.18 -0.12 -2.60 2.18

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co  (HKSE:01349) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2024 was HK$-2.6 Mil. Its Operating Income for the three months ended in Sep. 2024 was HK$-28.1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was HK$9.1 Mil.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
308 Cailun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.
Executives
Invesco Hong Kong Limited 2102 Investment manager
Shanghai Pharmaceuticals Holding Co., Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Headlines

No Headlines